New hope for uncontrollable movements
NCT ID NCT07365462
Summary
This study is testing whether an experimental drug called NBI-1065890 can reduce involuntary movements in adults with tardive dyskinesia. About 100 participants with moderate to severe symptoms will receive either the drug or a placebo for 8 weeks. Researchers will measure changes in movement severity and overall improvement.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.